Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
39,736,842
-
Total 13F shares
-
9,572,064
-
Share change
-
+3,830,394
-
Total reported value
-
$10,050,752
-
Price per share
-
$1.05
-
Number of holders
-
30
-
Value change
-
+$4,021,961
-
Number of buys
-
18
-
Number of sells
-
10
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q3 2024
As of 30 Sep 2024,
AEON Biopharma, Inc. - Class A Common Stock (AEON) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,572,064 shares.
The largest 10 holders included
Polar Asset Management Partners Inc., Blue Owl Capital Holdings LP, VANGUARD GROUP INC, Formidable Asset Management, LLC, BlackRock, Inc., Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, TWO SIGMA INVESTMENTS, LP, and Caprock Group, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.